|LETTER TO THE EDITOR
|Year : 2018 | Volume
| Issue : 4 | Page : 262
A rare case of pinealoblastoma in adult with complete response to treatment
Amrith Patel1, Sumit Goyal1, Udip Maheshwari1, Manish Sharma1, Ankush Jajodia2, Venkata Pradeep Babu Koyyala1
1 Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
2 Department of Radiology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
|Date of Web Publication||5-Oct-2018|
Dr. Ankush Jajodia
Department of Radiology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Patel A, Goyal S, Maheshwari U, Sharma M, Jajodia A, Babu Koyyala VP. A rare case of pinealoblastoma in adult with complete response to treatment. South Asian J Cancer 2018;7:262
|How to cite this URL:|
Patel A, Goyal S, Maheshwari U, Sharma M, Jajodia A, Babu Koyyala VP. A rare case of pinealoblastoma in adult with complete response to treatment. South Asian J Cancer [serial online] 2018 [cited 2020 Jan 27];7:262. Available from: http://journal.sajc.org/text.asp?2018/7/4/262/242797
Supratentorial primitive neuroectodermal tumors (SPNETs) usually arise from cerebrum or pineal gland and accounts for about 2.5% of pediatric brain tumors. SPNET arising from the pineal gland is known as pinealoblastomas, which are highly malignant embryonal tumors usually affects children and adolescents and are very rare in adults.
A 42-year-old male patient presented with a history of a headache and blurring of vision for 15 days. There was no history suggestive of any focal neurological deficits. Neuroimaging [Figure 1] showed a well-defined mass lesion of size 2 cm × 1.5 cm in the posterior aspect of the third ventricle along the hypothalo-pineal axis possibly a pineal gland tumor.
|Figure 1: Right: Presurgery: A circumscribed lesion with well-defined margins is seen involving the pineal gland, which has mixed intermediate and high signal on sagittal T2-weighted images. Left: Postsurgery/postchemotherapy/radiotherapy: Evidence of craniotomy and postoperative defect is noted in occipital bone. No altered signal intensity lesion is appreciated|
Click here to view
He underwent craniotomy and maximal safe resection of the tumor. Histopathological analysis showed pinealoblastoama (the WHO Grade IV) with MIB index of 30%. Immunohistochemistry was done which showed synaptophysin and chromogranin positivity. The postoperative imaging showed residual mass lesion with involvement of medial thalamus. The patient received craniospinal irradiation with vincristine-based concurrent chemotherapy (five cycles). Imaging at re-evaluation showed near-complete resolution of the tumor [Figure 2]. The patient received six cycles of adjuvant chemotherapy with vincristine, procarbazine, and lomustine. The imaging at the completion of the treatment showed complete resolution of the lesion with no residual abnormalities.
|Figure 2: Right: Presurgery: A well circumscribed tumor arising from the pineal gland shows contrast enhancement on sagittal T1- weighted image. Left: Postsurgery/postchemotherapy/radiotherapy: Evidence of craniotomy and postoperative defect is noted in occipital bone. No altered signal intensity lesion is appreciated|
Click here to view
Pinealoblastomas in an adult is a rare entity. In a retrospective review of 48 patients with the pineal gland tumors over 10 years, which included 35 children and 13 adults, pinealoblastoama was diagnosed only in six (12.5%) cases. In a review of treatment outcomes in pinealoblastoama from tertiary cancer hospital in India, there were 17 patients of pinealoblastoama with a median age of 14 years. After a median follow-up of 30 months following surgery and adjuvant chemoradiotherapy, disease recurrence and death were noted in 7 (41%) and 3 (17%) patients, respectively, with estimated median recurrence-free survival of 5.4 years. There were no standard guidelines to manage this malignancy in adults.
This case depicts a rare malignancy of the central nervous system which presented in an uncommon age group of the fifth decade. Although there are no standard guidelines for treatment of pinealoblastoama in an adult, surgical resection followed by craniospinal irradiation with boost to tumor bed along with chemotherapy gives a good response. Clinical trials with a larger number of patients are needed to look for the best treatment modality.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Gaffney CC, Sloane JP, Bradley NJ, Bloom HJ. Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment. J Neurooncol 1985;3:23-33.
Villà S, Miller RC, Krengli M, Abusaris H, Baumert BG, Servagi-Vernat S, et al.
Primary pineal tumors: Outcome and prognostic factors – A study from the rare cancer network (RCN). Clin Transl Oncol 2012;14:827-34.
Cho BK, Wang KC, Nam DH, Kim DG, Jung HW, Kim HJ, et al.
Pineal tumors: Experience with 48 cases over 10 years. Childs Nerv Syst 1998;14:53-8.
Biswas A, Mallick S, Purkait S, Gandhi A, Sarkar C, Singh M, et al.
Treatment outcome and patterns of failure in patients of pinealoblastoma: Review of literature and clinical experience from a regional cancer centre in North India. Childs Nerv Syst 2015;31:1291-304.
[Figure 1], [Figure 2]